100% of moneycontrol users recommend buying Marksans Pharma.
What's your call on Marksans Pharma today?
Read 10 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3218.40||0.96||3240.00||2420.00||54,830.54|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
RS Software (India) Recommended on Aug 12th 2014
Recommended price 430.00 | Peak from reco 829.30 82.59%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Marksans Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,383.13 crore.The company has reported a consolidated sales of Rs 202.40 crore and a Net Profit of Rs 25.92 crore for the quarter ended Jun 2014.
The company management includes Mark Saldanha - Chairman & Managing Director, B S Desai - Whole Time Director, S R Buddharaju - Director, Ajay S Joshi - Director, Naresh Balwant Wadhwa - Ind.& Non Exe.Director.
It is listed on the BSE with a BSE Code of 524404 and the NSE with an NSE Code of MARKSANS.
Its Registered office is at 11th Floor, Lotus Business Park,,Off New Link Road, Mumbai,Maharashtra - 400053.
Their Registrars are Bigshare Services Pvt. Ltd.